The core activity of Isanas AG is the development of new therapies for severe inflammatory diseases, such as multiple sclerosis, arthritis, asthma and others.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Development of novel therapies for inflammatory diseases
Development of novel therapies for severe inflammatory diseases such as multiple sclerosis; identification of new active ingredients, investigation of known active ingredients, and further development of selected substances up to use in patients.
Multiple Sclerosis programme
Programme «Multiple Sclerosis on Vacation» / «Multiple Sklerose macht Ferien», which, according to the website, is set to start soon; interested parties are asked to get in touch.
Comparisons
Isanas AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Isanas AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Isanas AG has claimed this profile, we'll publish editorial articles and case studies here together.